Jubilant Biosys Ltd, based in India, is a pharmaceutical company that stands out with its certifications from FDA, EDQM and WHO-GMP.
One of their notable products is ESLICARBAZEPINE ACETATE, with a corresponding US DMF Number 26927.
Remarkably, this DMF maintains an Active status since its submission on March 26, 2013, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of October 21, 2016, and payment made on June 16, 2016, indicating their dedication to facilitating drug approvals, Categorized as Type II